<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">Therefore, extrapolating conclusions from the observational data available on children who develop moderate to severe COVID-19 globally is difficult due to possible confounding by other factors. Published detailed clinical information is often lacking with regard to whether these children required high-level care due to COVID-19, or were simply RT-PCR SARS-CoV-2 positive and admitted due to an alternative diagnosis or active comorbidity at a time when community transmission of the virus in their geographic settings was high.
 <xref rid="bib27" ref-type="bibr">
  <sup>27</sup>
 </xref> Furthermore, a vast array of (not yet evidence-based) therapeutic options have been utilised in many of these descriptive studies, including antiviral agents, traditional medicine, antibiotics, and immunomodulatory agents, many of which have known adverse effects, further complicating the ability to ascertain whether complications in these cases were due to SARS-CoV-2 or other factors implicated in these presentations.
 <xref rid="bib36" ref-type="bibr">
  <sup>36</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib37" ref-type="bibr">
  <sup>37</sup>
 </xref>
</p>
